EcoDrugPlus

Ensembl ID : ENSDLAG00005015989
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSDLAG00005017221
Gene Symbol: -
Cross references: -
176 Possible Orthologues:

Ensembl ID : ENSDLAG00005017229
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSDLAG00005017438
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSDLAG00005017692
Gene Symbol: -
Cross references: -
230 Possible Orthologues:

Ensembl ID : ENSDLAG00005017700
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSDLAG00005017302
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSDLAG00005017539
Gene Symbol: -
Cross references: -
145 Possible Orthologues:

Ensembl ID : ENSDLAG00005017574
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSDLAG00005018322
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSDLAG00005018357
Gene Symbol: -
Cross references: -
250 Possible Orthologues:

Ensembl ID : ENSDLAG00005018027
Gene Symbol: -
1 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).